The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model

被引:35
作者
Matsuzaki, Yuichi [1 ]
Iwaki, Ryuma [1 ]
Reinhardt, James W. [1 ]
Chang, Yu-Chun [1 ,2 ]
Miyamoto, Shinka [1 ]
Kelly, John [1 ]
Zbinden, Jacob [1 ,3 ]
Blum, Kevin [1 ,3 ]
Mirhaidari, Gabriel [1 ,2 ]
Ulziibayar, Anudari [1 ]
Shoji, Toshihiro [1 ]
Breuer, Christopher K. [1 ,4 ]
Shinoka, Toshiharu [1 ,4 ,5 ]
机构
[1] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Regenerat Med, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Biomed Engn Grad Program, Columbus, OH 43210 USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43210 USA
[5] Nationwide Childrens Hosp, Heart Ctr, Dept Cardiothorac Surg, 700 Childrens Dr,T2294, Columbus, OH 43205 USA
关键词
Tissue engineering; Vascular graft; Biodegradable; Artery; Pore diameter; Large animal model; VASCULAR GRAFTS; POLARIZATION; FIBERS;
D O I
10.1016/j.actbio.2020.08.011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To date, there has been little investigation of biodegradable tissue engineered arterial grafts (TEAG) using clinically relevant large animal models. The purpose of this study is to explore how pore size of electrospun scaffolds can be used to balance neoarterial tissue formation with graft structural integrity under arterial environmental conditions throughout the remodeling process. TEAGs were created with an outer poly-epsilon-caprolactone (PCL) electrospun layer and an inner sponge layer composed of heparin conjugated 50:50 poly (l-lactide-co-epsilon-caprolactone) copolymer (PLCL). Outer electrospun layers were created with four different pore diameters (4, 7, 10, and 15 mu m). Fourteen adult female sheep underwent bilateral carotid artery interposition grafting (n = 3-4 /group). Our heparin-eluting TEAG was implanted on one side (n = 14) and ePTFE graft (n = 3) or non-heparin-eluting TEAG (n = 5) on the other side. Twelve of the fourteen animals survived to the designated endpoint at 8 weeks, and one animal with 4 mu m pore diameter graft was followed to 1 year. All heparin-eluting TEAGs were patent, but those with pore diameters larger than 4 mu m began to dilate at week 4. Only scaffolds with a pore diameter of 4 mu m resisted dilation and could do so for up to 1 year. At 8 weeks, the 10 mu m pore graft had the highest density of cells in the electrospun layer and macrophages were the primary cell type present. This study highlights challenges in designing bioabsorbable TEAGs for the arterial environment in a large animal model. While larger pore diameter TEAGs promoted cell infiltration, neotissue could not regenerate rapidly enough to provide sufficient mechanical strength required to resist dilation. Future studies will be focused on evaluating a smaller pore design to better understand long-term remodeling and determine feasibility for clinical use. Statement of Significance In situ vascular tissue engineering relies on a biodegradable scaffold that encourages tissue regeneration and maintains mechanical integrity until the neotissue can bear the load. Species-specific differences in tissue regeneration and larger mechanical forces often result in graft failure when scaling up from small to large animal models. This study utilizes a slow-degrading electrospun PCL sheath to reinforce a tissue engineered arterials graft. Pore size, a property critical to tissue regeneration, was controlled by changing PCL fiber diameter and the resulting effects of these properties on neotissue formation and graft durability was evaluated. This study is among few to report the effect of pore size on vascular neotissue formation in a large animal arterial model and also demonstrate robust neotissue formation. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 33 条
  • [1] Graft type for femoro-popliteal bypass surgery
    Ambler, Graeme K.
    Twine, Christopher P.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (02):
  • [2] Improvements in GORE-TEX® Vascular Graft performance by Carmeda® BioActive Surface heparin immobilization
    Begovac, PC
    Thomson, RC
    Fisher, JL
    Hughson, A
    Gällhagen, A
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 25 (05) : 432 - 437
  • [3] Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling
    Best, Cameron A.
    Szafron, Jason M.
    Rocco, Kevin A.
    Zbinden, Jacob
    Dean, Ethan W.
    Maxfield, Mark W.
    Kurobe, Hirotsugu
    Tara, Shuhei
    Bagi, Paul S.
    Udelsman, Brooks V.
    Khosravi, Ramak
    Yi, Tai
    Shinoka, Toshiharu
    Humphrey, Jay D.
    Breuer, Christopher K.
    [J]. ACTA BIOMATERIALIA, 2019, 94 : 183 - 194
  • [4] Evaluation of synthetic vascular grafts in a mouse carotid grafting model
    Chan, Alex H. P.
    Tan, Richard P.
    Michael, Praveesuda L.
    Lee, Bob S. L.
    Vanags, Laura Z.
    Ng, Martin K. C.
    Bursill, Christina A.
    Wise, Steven G.
    [J]. PLOS ONE, 2017, 12 (03):
  • [5] Large variations in absolute wall shear stress levels within one species and between species
    Cheng, Caroline
    Helderman, Frank
    Tempel, Dennie
    Segers, Dolf
    Hierck, Beerend
    Poelmann, Rob
    van Tol, Arie
    Duncker, Dirk J.
    Robbers-Visser, Danielle
    Ursem, Nicolette T. C.
    van Haperen, Rien
    Wentzel, Jolanda J.
    Gijsen, Frank
    van der Steen, Anton F. W.
    de Crom, Rini
    Krams, Rob
    [J]. ATHEROSCLEROSIS, 2007, 195 (02) : 225 - 235
  • [6] Spontaneous reversal of stenosis in tissue-engineered vascular grafts
    Drews, Joseph D.
    Pepper, Victoria K.
    Best, Cameron A.
    Szafron, Jason M.
    Cheatham, John P.
    Yates, Andrew R.
    Hor, Kan N.
    Zbinden, Jacob C.
    Chang, Yu-Chun
    Mirhaidari, Gabriel J. M.
    Ramachandra, Abhay B.
    Miyamoto, Shinka
    Blum, Kevin M.
    Onwuka, Ekene A.
    Zakko, Jason
    Kelly, John
    Cheatham, Sharon L.
    King, Nakesha
    Reinhardt, James W.
    Sugiura, Tadahisa
    Miyachi, Hideki
    Matsuzaki, Yuichi
    Breuer, Julie
    Heuer, Eric D.
    West, T. Aaron
    Shoji, Toshihiro
    Berman, Darren
    Boe, Brian A.
    Asnes, Jeremy
    Galantowicz, Mark
    Matsumura, Goki
    Hibino, Narutoshi
    Marsden, Alison L.
    Pober, Jordan S.
    Humphrey, Jay D.
    Shinoka, Toshiharu
    Breuer, Christopher K.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (537)
  • [7] Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model
    Freeman, John
    Chen, Aaron
    Weinberg, Roy J.
    Okada, Tamuru
    Chen, Changyi
    Lin, Peter H.
    [J]. ANNALS OF VASCULAR SURGERY, 2018, 49 : 295 - 303
  • [8] Variability of arterial wall shear stress, its dependence on vessel diameter and implications for Murray's Law
    Friedman, Morton H.
    [J]. ATHEROSCLEROSIS, 2009, 203 (01) : 47 - 48
  • [9] Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers
    Gao, Yaohua
    Yi, Tai
    Shinoka, Toshiharu
    Lee, Yong Ung
    Reneker, Darrell H.
    Breuer, Christopher K.
    Becker, Matthew L.
    [J]. ADVANCED HEALTHCARE MATERIALS, 2016, 5 (18) : 2427 - 2436
  • [10] Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds
    Garg, Koyal
    Pullen, Nicholas A.
    Oskeritzian, Carole A.
    Ryan, John J.
    Bowlin, Gary L.
    [J]. BIOMATERIALS, 2013, 34 (18) : 4439 - 4451